Foxp3 expressing CD4+ CD25+ and CD8+CD28− T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma

Control of Regulatory T Cell Development by the Transcription Factor <i>Foxp3</i>

Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187 · see citing works

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · see citing works

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151 · see citing works

Revisions in the International System for Staging Lung Cancer

Mountain, C. F. (1997) · CHEST Journal · doi:10.1378/chest.111.6.1710 · Cited by 4,565 · see citing works

N aturally A rising CD4+R egulatory T C ells for I mmunologic S elf -T olerance and N egative C ontrol of I mmune R esponses

Sakaguchi, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,293 · see citing works

An essential role for Scurfin in CD4+CD25+ T regulatory cells

Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,860 · see citing works

Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma

Liyanage, U. K., Moore, T. T., Joo, H., Tanaka, Y., Herrmann, V. M., Doherty, G. M., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,466 · see citing works

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

Woo, E. Y., Chu, C., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., & June, C. H. (2001) · PubMed · Cited by 1,113 · see citing works

Advances in Malignant Mesothelioma

Robinson, B. W. S., & Lake, R. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050152 · Cited by 1,075 · see citing works

Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells

Weiner, H. L. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820117.x · Cited by 850 · see citing works

Type 1 T regulatory cells

Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S. K., & Levings, M. K. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820105.x · Cited by 814 · see citing works

Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4

Chang, C.-C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S. M., Colonna, M., Cortesini, R., Dalla‐Favera, R., et al. (2002) · Nature Immunology · doi:10.1038/ni760 · Cited by 803 · see citing works

Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation

Woo, E. Y., Yeh, H., Chu, C., Schlienger, K., Carroll, R. G., Riley, J. L., Kaiser, L. R., & June, C. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4272 · Cited by 689 · see citing works

Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells

Viguier, M. A., Lemaı̂tre, F., VEROLA, O., Cho, M.-S., Gorochov, G., Dubertret, L., Bachelez, H., Kourilsky, P., & Ferradini, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1444 · Cited by 686 · see citing works

Increase of regulatory T cells in the peripheral blood of cancer patients.

Wolf, A. M., Wolf, D. G. F., Steurer, M., Gastl, G., Gunsilius, E., & Grubeck-Loebenstein, B. (2003) · PubMed · Cited by 655 · see citing works

Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma

Ormandy, L. A., Hillemann, T., Wedemeyer, H. H., Manns, M. P., Greten, T. F., & Korangy, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3232 · Cited by 643 · see citing works

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

Marshall, N. A., Christie, L. E., Munro, L., Culligan, D. J., Johnston, P. W., Barker, R. N., & Vickers, M. A. (2003) · Blood · doi:10.1182/blood-2003-07-2594 · Cited by 508 · see citing works

Tumor Cyclooxygenase-2/Prostaglandin E2–Dependent Promotion of FOXP3 Expression and CD4+CD25+ T Regulatory Cell Activities in Lung Cancer

Sharma, S. P., Yang, S.-C., Zhu, L., Reckamp, K. L., Gardner, B. K., Baratelli, F. E., Huang, M., Batra, R. K., & Dubinett, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0141 · Cited by 502 · see citing works

Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.

Ichihara, F., Kono, K., Takahashi, A., Kawaida, H., Sugai, H., & Fujii, H. (2003) · PubMed · Cited by 491 · see citing works

CD4 + CD25 + regulatory T cells in patients with gastrointestinal malignancies

Sasada, T., Kimura, M., Yoshida, Y., Kanai, M., & Takabayashi, A. (2003) · Cancer · doi:10.1002/cncr.11618 · Cited by 485 · see citing works

Human CD25+CD4+ T Suppressor Cell Clones Produce Transforming Growth Factor β, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells

Levings, M. K., Sangregorio, R., Sartirana, C., Moschin, A. L., Battaglia, M., Orban, P. C., & Roncarolo, M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021139 · Cited by 429 · see citing works

A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions

Putnam, J. B., Light, R. W., Rodriguez, R. M., Ponn, R. B., Olak, J., Pollak, J. S., Lee, R. B., Payne, D. K., Graeber, G., & Kovitz, K. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991115)86:10 · Cited by 385 · see citing works

Human CD4+CD25+ regulatory T cells

Baecher‐Allan, C. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2003.12.005 · Cited by 385 · see citing works

Expression of FoxP3, a key molecule in CD4+CD25+ regulatory T cells, in adult T‐cell leukaemia/lymphoma cells

Karube, K., Ohshima, K., Tsuchiya, T., Yamaguchi, T., Kawano, R., Suzumiya, J., Utsunomiya, A., Harada, M., & Kikuchi, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04999.x · Cited by 292 · see citing works

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

Schaefer, C. P., Kim, G. G., Albers, A. E., Hoermann, K., Myers, E., & Whiteside, T. L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602407 · Cited by 270 · see citing works

Regulatory functions of CD8+CD28– T cells in an autoimmune disease model

Najafian, N., Chitnis, T., Salama, A. D., Zhu, B., Benou, C., Yuan, X., Clarkson, M. R., Sayegh, M. H., & Khoury, S. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17935 · Cited by 260 · see citing works

Immunoregulatory T cells in tumor immunity

Terabe, M., & Berzofsky, J. A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.01.010 · Cited by 259 · see citing works

Alloantigen specific CD8+CD28− FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity

Manavalan, J. S., Kim‐Schulze, S., Scotto, L., Naiyer, A. J., Vlad, G., Colombo, P. C., Marboe, C. C., MANCINI, D. M., Cortesini, R., & Suciu‐Foca, N. (2004) · International Immunology · doi:10.1093/intimm/dxh107 · Cited by 256 · see citing works

Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells

Berger, C. L., Tigelaar, R. E., Cohen, J. V., Mariwalla, K., Trinh, J., Wang, N., & Edelson, R. L. (2004) · Blood · doi:10.1182/blood-2004-06-2181 · Cited by 242 · see citing works

Cutaneous T Cell Lymphoma

Edelson, R. L. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03705.x · Cited by 175 · see citing works

Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28− T cells and inhibit both T-Cell proliferation and CTL function

Filaci, G., Fravega, M., Negrini, S., Procopio, F., Fenoglio, D., Rizzi, M., Brenci, S., Contini, P., Olive, D., Ghio, M., et al. (2004) · Human Immunology · doi:10.1016/j.humimm.2003.12.001 · Cited by 163 · see citing works

Rapid turnover of the CD8(+)CD28(−) T-cell subset of effector cells in the circulation of patients with head and neck cancer

Tsukishiro, T., Donnenberg, A. D., & Whiteside, T. L. (2003) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0395-6 · Cited by 158 · see citing works

Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome

Meloni, F., Vitulo, P., Bianco, A. M., Paschetto, E., Morosini, M., Cascina, A., Mazzucchelli, I., Ciardelli, L. M., Oggionni, T., Fietta, A. M., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000116565.86752.6b · Cited by 130 · see citing works

Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma

DeLong, P. A., Carroll, R. G., Henry, A. C., Tanaka, T. N., Ahmad, S., Leibowitz, M. S., Sterman, D. H., June, C. H., Albelda, S. Μ., & Vonderheide, R. H. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.3.1644 · Cited by 120 · see citing works

Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells

Wei, W., Morris, G. P., & Kong, Y.-C. M. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0444-1 · Cited by 117 · see citing works

Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28− T suppressor cells

Scotto, L., Naiyer, A. J., Galluzzo, S., Rossi, P. C., Manavalan, J. S., Kim‐Schulze, S., Fang, J., Favera, R. D., Cortesini, R., & Suciu‐Foca, N. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.09.004 · Cited by 116 · see citing works

Regulatory CD8+CD28− T cells in heart transplant recipients

Colovai, A. I., Mirza, M. R., Vlad, G., Wang, S. U., Ho, E. K., Cortesini, R., & Suciu‐Foca, N. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00742-5 · Cited by 114 · see citing works

Untitled work

(2003) · PubMed · Cited by 110 · see citing works

Distribution of CD4(+)CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer

Kawaida, H., Kono, K., Takahashi, A., Sugai, H., Mimura, K., Miyagawa, N., Omata, H., Ooi, A., & Fujii, H. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.10.004 · Cited by 101 · see citing works

CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.

Okita, R., Saeki, T., Takashima, S., Yamaguchi, Y., & Toge, T. (2005) · Oncology Report · doi:10.3892/or.14.5.1269 · Cited by 94 · see citing works

CD4+CD25+ Regulatory T Lymphocytes in Malignant Pleural Effusion

Chen, Y., Shi, H., Qin, X., Mo, W., Liang, X.-D., Huang, Z.-X., Yang, H., & Wu, C. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-588oc · Cited by 75 · see citing works

High frequency of immune dysfunctions in asbestos workers and in patients with malignant mesothelioma

Lew, F., Tsang, P. H., Holland, J. F., Warner, N. L., Selikoff, I. J., & Bekesi, J. G. (1986) · Journal of Clinical Immunology · doi:10.1007/bf00918702 · Cited by 61 · see citing works

Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients

Fattorossi, A. (2003) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.09.020 · Cited by 61 · see citing works

Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma.

Haslam, P. L., Lukoszek, A., Merchant, J. A., & Turner-Warwick, M. E. H. (1978) · PubMed Central · Cited by 54 · see citing works

Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos/chrysotile-A

Wu, P., Hyodoh, F., Hatayama, T., Sakaguchi, H., Hatada, S., Miura, Y., Takata‐Tomokuni, A., Katsuyama, H., & Otsuki, T. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.11.005 · Cited by 39 · see citing works

CD8+CD28− T suppressor cells represent a distinct subset in a heterogeneous population

Colovai, A. I., Ciubotariu, R., Liu, Z., Cortesini, R., & Suciu‐Foca, N. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)01927-8 · Cited by 19 · see citing works

Whole blood assay for assessment of the mixed lymphocyte reaction

Bromelow, K. V., Hirst, W. J. R., Mendes, R. L., Winkley, A., Smith, I. E., O'Brien, M. E. R., & Souberbielle, B. E. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00311-2 · Cited by 15 · see citing works

Systemic effects of cancer: role of multiple proteases and their toxic peptide products.

Rubin, H. (2005) · PubMed · Cited by 14 · see citing works

[Analysis of CD8(+) and CD8(+)CD28(-) cell subsets in patients with hepatocellular carcinoma].

Qiu, Y., Yang, C. C., Chen, L.-B., & Wang, Q. (2002) · PubMed · Cited by 6 · see citing works

Insights Into Novel Biological Mediators of Clinical Manifestations in Cancer

Sanchez, O. H. (2004) · AACN Clinical Issues Advanced Practice in Acute & Critical Care · doi:10.1097/00044067-200401000-00009 · Cited by 5 · see citing works

Systemic Effects of Cancer

Reeves, B., & Bernard, S. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.01913-4 · Cited by 4 · see citing works

Systemic immunity in cancer

Hiam-Galvez, K. J., Allen, B. M., & Spitzer, M. H. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00347-z · Cited by 1,400 · see citing works

T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment

Crespo, J., Sun, H., Welling, T. H., Tian, Z., & Zou, W. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.12.003 · Cited by 752 · see citing works

CD8+ CD28− and CD8+ CD57+ T cells and their role in health and disease: CD8+ CD28− (CD8+ CD57+) T cells in health and disease

Strioga, M., Pasukoniene, V., & Characiejus, D. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03470.x · Cited by 505 · see citing works

The interplay between immunosenescence and age-related diseases

Barbé‐Tuana, F. M., Funchal, G. A., Schmitz, C. R. R., Maurmann, R. M., & Bauer, M. E. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00806-z · Cited by 385 · see citing works

Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment

Zhao, Y., Shao, Q., & Peng, G. (2020) · Cellular &amp; Molecular Immunology · doi:10.1038/s41423-019-0344-8 · Cited by 382 · see citing works

T Cell Replicative Senescence in Human Aging

P. Chou, J., & B. Effros, R. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219711 · Cited by 323 · see citing works

Quantitative DNA Methylation Analysis of FOXP3 as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue

Wieczorek, G., Asemissen, A. M., Model, F., Türbachova, I., Floess, S., Liebenberg, V., Baron, U., Stauch, D., Kotsch, K., Pratschke, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2361 · Cited by 315 · see citing works

Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy

Liu, X., Hartman, C. L., Li, L., Albert, C. J., Si, F., Gao, A., Huang, L. J., Zhao, Y., Lin, W., Hsueh, E. C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz6314 · Cited by 278 · see citing works

Effector, Memory, and Dysfunctional CD8+T Cell Fates in the Antitumor Immune Response

Reiser, J., & Banerjee, A. (2016) · Journal of Immunology Research · doi:10.1155/2016/8941260 · Cited by 256 · see citing works

The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology

Huff, W. X., Kwon, J. H., Henriquez, M., Fetcko, K., & Dey, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112810 · Cited by 217 · see citing works

Tumor-Derived γδ Regulatory T Cells Suppress Innate and Adaptive Immunity through the Induction of Immunosenescence

Ye, J., Ma, C., Hsueh, E. C., Eickhoff, C. S., Zhang, Y., Varvares, M. A., Hoft, D. F., & Peng, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202369 · Cited by 203 · see citing works

Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

Griffiths, R. W., Elkord, E., Gilham, D. E., Ramani, V., Clarke, N. W., Stern, P. L., & Hawkins, R. E. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0318-z · Cited by 201 · see citing works

Human regulatory T cells induce T-lymphocyte senescence

Ye, J., Huang, X., Hsueh, E. C., Zhang, Q., Ma, C., Zhang, Y., Varvares, M. A., Hoft, D. F., & Peng, G. (2012) · Blood · doi:10.1182/blood-2012-03-416040 · Cited by 198 · see citing works

TLR8 signaling enhances tumor immunity by preventing tumor‐induced T‐cell senescence

Ye, J., Ma, C., Hsueh, E. C., Dou, J., Mo, W., Liu, S., Han, B., Huang, Y., Zhang, Y., Varvares, M. A., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201403918 · Cited by 161 · see citing works

Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms

Gholami, M. D., Kardar, G. A., Saeedi, Y., Heidari, S., Garssen, J., & Falak, R. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.002 · Cited by 140 · see citing works

Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence.

Dock, J., & Effros, R. B. (2011) · Europe PMC (PubMed Central) · Cited by 137 · see citing works

CD28 Negative T Cells: Is Their Loss Our Gain?

Mou, D., Espinosa, J. R., Lo, D. J., & Kirk, A. D. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12937 · Cited by 137 · see citing works

The Aging Immune System and Its Relationship with Cancer

Foster, A. D., Sivarapatna, A., & Gress, R. E. (2011) · Aging Health · doi:10.2217/ahe.11.56 · Cited by 136 · see citing works

Immunity and Immune Suppression in Human Ovarian Cancer

Preston, C. C., Goode, E. L., Hartmann, L. C., Kalli, K. R., & Knutson, K. L. (2011) · Immunotherapy · doi:10.2217/imt.11.20 · Cited by 130 · see citing works

CD8+ Tregs in lupus, autoimmunity, and beyond

Dinesh, R. K., Skaggs, B. J., Cava, A. L., Hahn, B. H., & Singh, R. P. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.03.006 · Cited by 128 · see citing works

Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion

Montes, C. L., Chapoval, A. I., Nelson, J., Orhue, V., Zhang, X., Schulze, D. H., Strome, S. E., & Gastman, B. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2282 · Cited by 127 · see citing works

Generation of highly suppressive adaptive CD8+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation

Mahic, M., Henjum, K., Yaqub, S., Bjørnbeth, B. A., Torgersen, K. M., Taskén, K., & Aandahl, E. M. (2008) · European Journal of Immunology · doi:10.1002/eji.200737529 · Cited by 124 · see citing works

Lipids as Regulators of Cellular Senescence

Hamsanathan, S., & Gurkar, A. U. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.796850 · Cited by 120 · see citing works

Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer

Fietta, A. M., Morosini, M., Passadore, I., Cascina, A., Draghi, P., Dore, R., Rossi, S. M., Pozzi, E., & Meloni, F. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.03.012 · Cited by 116 · see citing works

Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy

Liu, X., Hoft, D. F., & Peng, G. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133679 · Cited by 113 · see citing works

Transplantation Survival Is Maintained by Granzyme B+ Regulatory Cells and Adaptive Regulatory T Cells

Gondek, D. C., DeVries, V., Nowak, E. C., Lu, L., Bennett, K. A., Scott, Z., & Noelle, R. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4752 · Cited by 114 · see citing works

Immunotherapies for non-small-cell lung cancer and mesothelioma

Thomas, A., & Hassan, R. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70126-2 · Cited by 110 · see citing works

The Role of the Immune System in Cutaneous Squamous Cell Carcinoma

Bottomley, M. J., Thomson, J., Harwood, C. A., & Leigh, I. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082009 · Cited by 109 · see citing works

Prevention of Both Direct and Cross-Priming of Antitumor CD8+ T-Cell Responses following Overproduction of Prostaglandin E2 by Tumor CellsIn vivo

Ahmadi, M., Emery, D. C., & Morgan, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1060 · Cited by 105 · see citing works

Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4 + CD25 – cells

Aarts‐Riemens, T., Emmelot, M. E., Verdonck, L. F., & Mutis, T. (2008) · European Journal of Immunology · doi:10.1002/eji.200737590 · Cited by 101 · see citing works

CD8+ Tregs revisited: A heterogeneous population with different phenotypes and properties

Niederlová, V., Tsyklauri, O., Chadimová, T., & Štěpánek, O. (2021) · European Journal of Immunology · doi:10.1002/eji.202048614 · Cited by 98 · see citing works

CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion

Qin, X., Shi, H., Deng, J., Liang, Q.-L., Jiang, J., & Ye, Z. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2641 · Cited by 94 · see citing works

Tumor extracellular vesicle–derived PD-L1 promotes T cell senescence through lipid metabolism reprogramming

Ma, F., Liu, X., Zhang, Y., Tao, Y., Zhao, L., Abusalamah, H., Huffman, C., Harbison, R. A., Puram, S. V., Wang, Y., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adm7269 · Cited by 93 · see citing works

Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients

Kotsakis, A. P., Koinis, F., Katsarou, A., Gioulbasani, M., Aggouraki, D., Kentepozidis, N. K., Georgoulias, V., & Vetsika, E. (2016) · Scientific Reports · doi:10.1038/srep39247 · Cited by 94 · see citing works

Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity

Gao, A., Liu, X., Lin, W., Wang, J., Wang, S., Si, F., Huang, L. J., Zhao, Y., Sun, Y., & Peng, G. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001536 · Cited by 87 · see citing works

Immunological Effects of the TGFβ-Blocking Antibody GC1008 in Malignant Pleural Mesothelioma Patients

Stevenson, J. P., Kindler, H. L., Papasavvas, E., Sun, J., Jacobs-Small, M., Hull, J., Schwed, D., Ranganathan, A., Newick, K., Heitjan, D. F., et al. (2013) · OncoImmunology · doi:10.4161/onci.26218 · Cited by 85 · see citing works

Peripheral CD4+CD25+ TREG Cell Counts and the Response to Extracorporeal Photopheresis in Lung Transplant Recipients

Meloni, F., Cascina, A., Miserere, S., Perotti, C. G., Vitulo, P., & Fietta, A. M. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.10.227 · Cited by 86 · see citing works

Changes of CD4+CD25+FOXP3+ and CD8+CD28− regulatory T cells in non-small cell lung cancer patients undergoing surgery

Chen, C., Chen, D., Zhang, Y., Chen, Z., Zhu, W., Zhang, B., Wang, Z., & Le, H. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.12.004 · Cited by 84 · see citing works

Osteoclast Activated FoxP3+ CD8+ T-Cells Suppress Bone Resorption in vitro

Buchwald, Z. S., Kiesel, J. R., DiPaolo, R. J., Pagadala, M. S., & Aurora, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038199 · Cited by 83 · see citing works

Telomerase induction in T cells: A cure for aging and disease?

Effros, R. B. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.11.005 · Cited by 82 · see citing works

CD8+CD28− cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients

Karagöz, B., Bilgi, O., Gümüş, M., Erikçi, A. A., Sayan, Ö., Türken, O., Kandemir, E. G., Öztürk, A., & Yaylacı, M. (2009) · Medical Oncology · doi:10.1007/s12032-008-9165-9 · Cited by 80 · see citing works

Cutting Edge: Tumor-Specific CD8+ T Cells Infiltrating Prostatic Tumors Are Induced to Become Suppressor Cells

Shafer-Weaver, K., Anderson, M. J. M., Stagliano, K. E., Malyguine, A. M., Greenberg, N. M., & Hurwitz, A. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900848 · Cited by 79 · see citing works

Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients

Fan, Y., Du, R., Wei, F., Zhao, H., Yu, J., Wang, C., Zhan, Z., Ding, T., Ren, X., Chen, X., et al. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1751-z · Cited by 78 · see citing works

Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy

Jeong, S., & Park, S. (2020) · Immune Network · doi:10.4110/in.2020.20.e3 · Cited by 75 · see citing works

Immune Aging and Immunotherapy in Cancer

Kaiser, M., Semeraro, M. D., Herrmann, M., Absenger, G., Gerger, A., & Renner, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137016 · Cited by 78 · see citing works

The twilight of the immune system: The impact of immunosenescence in aging

Feehan, J., Tripodi, N., & Apostolopoulos, V. (2021) · Maturitas · doi:10.1016/j.maturitas.2021.02.006 · Cited by 76 · see citing works

The cross-talk between dendritic and regulatory T cells: good or evil?

Hubert, P., Jacobs, N., Caberg, J., Boniver, J., & Delvenne, P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106694 · Cited by 75 · see citing works

The role of regulatory T cells in malignant glioma.

Sonabend, A. M., Rolle, C. E., & Lesniak, M. S. (2008) · PubMed · Cited by 74 · see citing works

The senescence journey in cancer immunoediting

Zingoni, A., Antonangeli, F., Sozzani, S., Santoni, A., Cippitelli, M., & Soriani, A. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01973-5 · Cited by 74 · see citing works

Elevated level of peripheral CD8+CD28− T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy

Song, G., Wang, X., Jia, J., Yuan, Y., Fengling, W., Zhou, X., Yang, H., Ren, J., Gu, J., & Lyerly, H. K. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1424-8 · Cited by 73 · see citing works

Effects of Physical Exercise on Markers of Cellular Immunosenescence: A Systematic Review

Dinh, H. C., Beyer, I., Mets, T. F., Onyema, O. O., Njemini, R., Renmans, W., Waele, M. D., Jochmans, K., Meeren, S. V., & Bautmans, I. (2016) · Calcified Tissue International · doi:10.1007/s00223-016-0212-9 · Cited by 73 · see citing works

Age-associated inflammation connects ras-induced senescence to stem cell dysfunction and epidermal malignancy

Golomb, L., Sagiv, A., Pateras, I. S., Maly, A., Krizhanovsky, V, Gorgoulis, V. G., Oren, M., & Ben-Yehuda, A. (2015) · Cell Death &amp; Differentiation · doi:10.1038/cdd.2015.21 · Cited by 71 · see citing works

The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression

Kim, C. M., Lee, J. B., Shin, S. J., Ahn, J. B., Lee, M., & Kim, H. S. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100577 · Cited by 75 · see citing works

Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to Disease Activity Score-28

Sempere-Ortells, J. M., Pérez-García, V., Marín-Alberca, G., Peris-Pertusa, A., Benito, J. M., de la Calle, F. M. M., Zubcoff, J., & Navarro-Blasco, F. J. (2009) · Autoimmunity · doi:10.3109/08916930903061491 · Cited by 69 · see citing works

Immunomodulatory Effect of Lentinan on Aberrant T Subsets and Cytokines Profile in Non-small Cell Lung Cancer Patients

Wang, X.-E., Wang, Y.-H., Zhou, Q., Peng, M., Zhang, J., Chen, M., Ma, L., & Xie, G. (2018) · Pathology & Oncology Research · doi:10.1007/s12253-018-0545-y · Cited by 69 · see citing works

Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer

Yasumoto, K., Hanagiri, T., & Takenoyama, M. (2009) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-008-0433-6 · Cited by 64 · see citing works

CD8+ T Cell Senescence: Lights and Shadows in Viral Infections, Autoimmune Disorders and Cancer

Tedeschi, V., Paldino, G., Kunkl, M., Paroli, M., Sorrentino, R., Tuosto, L., & Fiorillo, M. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063374 · Cited by 62 · see citing works

Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer

Knutson, K. L., Maurer, M. J., Preston, C. C., Moysich, K. B., Goergen, K. M., Hawthorne, K. M., Cunningham, J. M., Odunsi, K. O., Hartmann, L. C., Kalli, K. R., et al. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1753-x · Cited by 62 · see citing works

Tumor-associated macrophages in thoracic malignancies

Lievense, L. A., Bezemer, K., Aerts, J. G. J. V., & Hegmans, J. P. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.02.017 · Cited by 60 · see citing works

Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients

Yang, Z., Yang, Z.-Y., Zhang, L.-D., PingBie, Wang, S., Ma, K., Li, X., & Dong, J. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.09.011 · Cited by 56 · see citing works

T-Cell Tolerance in Cancer

Nurieva, R., Wang, J., & Sahoo, A. (2013) · Immunotherapy · doi:10.2217/imt.13.33 · Cited by 56 · see citing works

Selective elimination of immunosuppressive T cells in patients with multiple myeloma

Awwad, M. H. S., Mahmoud, A., Bruns, H., Echchannaoui, H., Kriegsmann, K., Lutz, R., Raab, M. S., Bertsch, U., Munder, M., Jauch, A. S., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01172-x · Cited by 54 · see citing works

FoxP3+CD25+CD8+T-Cell Induction during Primary Simian Immunodeficiency Virus Infection in Cynomolgus Macaques Correlates with Low CD4+T-Cell Activation and High Viral Load

Karlsson, I., Malleret, B., Brochard, P., Delache, B., Calvo, J., Grand, R. L., & Vaslin, B. (2007) · Journal of Virology · doi:10.1128/jvi.01466-07 · Cited by 54 · see citing works

Suppressive effects of gemcitabine plus cisplatin chemotherapy on regulatory T cells in nonsmall-cell lung cancer

Chen, C., Chen, Z., Chen, D., Zhang, B., Wang, Z., & Le, H. (2015) · Journal of International Medical Research · doi:10.1177/0300060514561504 · Cited by 48 · see citing works

Functionally Suppressive CD8 T Regulatory Cells Are Increased in Patients with Multiple Myeloma: A Cause for Immune Impairment

Raja, K. R. M., Kubiczková, L., Říhová, L., Piskáček, M., Všianská, P., Héžová, R., Pour, L., & Hájek, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049446 · Cited by 48 · see citing works

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events

Bai, R., Chen, N., Chen, X., Li, L., Song, W., Li, W., Zhao, Y., Zhang, Y., Han, F., Lyu, Z., et al. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0052 · Cited by 46 · see citing works

Glioma immunotherapy by IL‐21 gene‐modified cells or by recombinant IL‐21 involves antibody responses

Daga, A., Orengo, A. M., Gangemi, R. M. R., Marubbi, D., Perera, M., Comes, A., Ferrini, S., & Corte, G. (2007) · International Journal of Cancer · doi:10.1002/ijc.22901 · Cited by 45 · see citing works

Polyfunctional KLRG-1+CD57+ Senescent CD4+ T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients

Ramello, M. C., Núñez, N. G., Tosello, J., Bossio, S., Canale, F. P., Abrate, C. P., Ponce, N. E., del Castillo, A., Ledesma, M., Viel, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.713132 · Cited by 43 · see citing works

Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients

Torisu‐Itakura, H., Lee, J. H., Huynh, Y., Ye, X., Essner, R., & Morton, D. L. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318158795b · Cited by 43 · see citing works

Regulatory T cells and potential inmmunotherapeutic targets in lung cancer

Zhang, D., Chen, Z., Wang, D. C., & Wang, X. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9566-0 · Cited by 42 · see citing works

Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

Veltman, J. D., Lambers, M. E. H., van Nimwegen, M., de Jong, S., Hendriks, R. W., Hoogsteden, H. C., Aerts, J. G. J. V., & Hegmans, J. P. (2010) · BioMed Research International · doi:10.1155/2010/798467 · Cited by 41 · see citing works

Current Issues in Malignant Pleural Mesothelioma Evaluation and Management

Ai, J., & Stevenson, J. P. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0122 · Cited by 40 · see citing works

Tumor-Reactive CD8+ Early Effector T Cells Identified at Tumor Site in Primary and Metastatic Melanoma

Anichini, A., Molla, A., Vegetti, C., Bersani, I., Zappasodi, R., Arienti, F., Ravagnani, F., Maurichi, A., Patuzzo, R., Santinami, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2028 · Cited by 40 · see citing works

Clinical and immunological evaluation of 12‐month azithromycin therapy in chronic lung allograft rejection

Meloni, F., Solari, N., Morosini, M., Cascina, A., Oggionni, T., Bini, F., Viganò, M., & Maria, F. A. (2011) · Clinical Transplantation · doi:10.1111/j.1399-0012.2011.01435.x · Cited by 39 · see citing works

CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer

Miotto, D., Cascio, N. L., Stendardo, M., Querzoli, P., Pedriali, M., Rosa, E. D., Fabbri, L. M., Mapp, C. E., & Boschetto, P. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.12.012 · Cited by 39 · see citing works

Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism

Rosa, V. D., Rella, F. D., Giacomo, A. D., & Matarese, G. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.001 · Cited by 38 · see citing works

Changes in regulatory T cells in patients with ovarian cancer undergoing surgery: Preliminary results

Wu, M. C., Chen, X., Lou, J., Zhang, S., Zhang, X., Huang, L., Sun, R., Huang, P., Pan, S., & Wang, F. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.04.004 · Cited by 38 · see citing works

NK‐ and T‐cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti‐CTLA‐4 therapy

Sottile, R., Tannazi, M., Johansson, M. H., Cristiani, C. M., Calabrò, L., Ventura, V., Cutaia, O., Chiarucci, C., Covre, A., Garofalo, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32363 · Cited by 38 · see citing works

T-cell Exhaustion in Organ Transplantation

Angeletti, A., Cantarelli, C., Riella, L. V., Fribourg, M., & Cravedi, P. (2021) · Transplantation · doi:10.1097/tp.0000000000003851 · Cited by 38 · see citing works

Adjuvant immunotherapy for non-small cell lung cancer

Tucker, Z. C. G., Laguna, B. A., Moon, E. K., & Singhal, S. K. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.008 · Cited by 38 · see citing works

What's the place of immunotherapy in malignant mesothelioma treatments?

Grégoire, M. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.1.11361 · Cited by 37 · see citing works

A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3+ CD8 T Cells

Buchwald, Z. S., Yang, C., Nellore, S., Shashkova, E. V., Davis, J. L., Cline, A., Ko, J., Novack, D. V., DiPaolo, R. J., & Aurora, R. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2472 · Cited by 36 · see citing works

Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8 + T cells in patients with advanced NSCLC

Naigeon, M., Dugage, M. R., Danlos, F., Boselli, L., Jouniaux, J.-M., de Oliveira, C., Ferrara, R., Duchemann, B., Berthot, C., Girard, L., et al. (2023) · Science Advances · doi:10.1126/sciadv.adh0708 · Cited by 35 · see citing works

Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data

Xue, L., Lu, H., He, J., Zhao, X., Zhong, L., Zhang, Z.-Z., & Xu, Z.-F. (2009) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2009.01013.x · Cited by 35 · see citing works

Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression

Mondello, P., Cuzzocrea, S., Navarra, M., & Mian, M. (2017) · Oncotarget · doi:10.18632/oncotarget.14610 · Cited by 34 · see citing works

A fresh look at a neglected regulatory lineage: CD8+Foxp3+ Regulatory T cells

Liston, A., & Aloulou, M. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.05.004 · Cited by 34 · see citing works

A Novel CAR Expressing NK Cell Targeting CD25 With the Prospect of Overcoming Immune Escape Mechanism in Cancers

Dehbashi, M., Hojati, Z., Motovali-Bashi, M., Ganjalikhany, M. R., Cho, W. C. S., Shimosaka, A., Navabi, P., & Ganjalıkhani-Hakemi, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.649710 · Cited by 31 · see citing works

Immunology of Aging and Cancer Development

Fülöp, T., Larbi, A., Kotb, R. R., & Pawelec, G. (2013) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000343599 · Cited by 31 · see citing works

Phenotype molding of T cells in colorectal cancer by single‐cell analysis

Di, J., Liu, M., Fan, Y., Gao, P., Wang, Z., Jiang, B., & Su, X. (2020) · International Journal of Cancer · doi:10.1002/ijc.32856 · Cited by 31 · see citing works

Features of Immunosenescence in Women Newly Diagnosed With Breast Cancer

Trintinaglia, L., Bandinelli, L. P., Grassi‐Oliveira, R., Petersen, L. E., Anzolin, M., Correa, B. L., Schuch, J. B., & Bauer, M. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01651 · Cited by 29 · see citing works

Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer

Valenzuela-Membrives, M. D. M., García, F. P., Sánchez‐Palencia, A., Ruiz‐Cabello, F., Gómez‐Morales, M., León, M. T. M., Galindo-Angel, I., & Fárez‐Vidal, M. E. (2016) · Oncotarget · doi:10.18632/oncotarget.12264 · Cited by 28 · see citing works

Tumor Cell Repopulation between Cycles of Chemotherapy is Inhibited by Regulatory T-Cell Depletion in a Murine Mesothelioma Model

Wu, L., Yun, Z., Tagawa, T., Rey‐McIntyre, K., Anraku, M., & de Perrot, M. E. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182208ee0 · Cited by 28 · see citing works

Local effector failure in mesothelioma is not mediated by CD4+CD25+T-regulator cells

Jackaman, C., Cornwall, S. M. J., Lew, A. M., Zhan, Y., Robinson, B. W. S., & Nelson, D. J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00101008 · Cited by 26 · see citing works

FOXP3+regulatory T cells as biomarkers in human malignancies

Bignone, P. A., & Banham, A. H. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712590802494022 · Cited by 25 · see citing works

IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells

Plaumann, J., Engelhardt, M., Awwad, M. H. S., Echchannaoui, H., Amann, E., Raab, M. S., Hillengaß, J., Halama, N., Neuber, B., Müller‐Tidow, C., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2230-0 · Cited by 24 · see citing works

Current State of Vaccine Therapies in Non–Small-Cell Lung Cancer

Romero, P. J. (2008) · Clinical Lung Cancer · doi:10.3816/clc.2008.s.005 · Cited by 24 · see citing works

Osteoclasts and CD8 T Cells Form a Negative Feedback Loop That Contributes to Homeostasis of Both the Skeletal and Immune Systems

Buchwald, Z. S., & Aurora, R. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/429373 · Cited by 24 · see citing works

Expression of GARP Is Increased in Tumor-Infiltrating Regulatory T Cells and Is Correlated to Clinicopathology of Lung Cancer Patients

Jin, H., Sun, L., Tang, L., Yu, W., & Li, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00138 · Cited by 22 · see citing works

Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls

Mazzoccoli, G., Sothern, R. B., Parrella, P., Muscarella, L. A., Fazio, V. M., Giuliani, F., Polyakova, V. O., & Kvetnoy, I. M. (2011) · Clinical and Experimental Medicine · doi:10.1007/s10238-011-0153-6 · Cited by 20 · see citing works

Changes of CD4~+CD25~+ T cells and expression of foxp3 mRNA in peripheral blood mononuclear cell from patients with lung cancer and breast cancer

Cui, Y. (2006) · Journal of Jilin University

Significance of measurement of CD4+ CD25+ FoxP3+ egulatory T cell in patients with lung cancer

Liu, J., Wang, L., Wang, Y., & Li, M. (2009) · Central Plains Medical Journal · doi:10.3760/cma.j.issn.1674-4756.2009.08.002

Expression of CD4~+CD25~+ Regulatory T Cells in Patients with Lung Cancer and Its Clinical Significance

Li, M. (2010) · Journal of Medical Forum

The effect of chemotherapy on the number of the CD4~+ CD25~+ Foxp3~+ Treg cells in the peipheral blood of patients with lung cancer

Liao, G. (2011) · Chinese Journal of Clinical Oncology and Rehabilitation

Increased CD4+CD25+FOXP3+ Regulatory T Cells in Cancer Patients from Conversion of CD4+CD25– T Cells through Tumor-Derived Factors

Mao, C., Wang, S., Jiang, Q., Tong, J., Ma, J., Yang, M., Xu, X., Qiu, G., Shao, Q., Li, L., et al. (2008) · Onkologie · doi:10.1159/000121360 · Cited by 24 · see citing works